Evaluation of the effect of cannabidiol in the treatment of dystonia
Phase 3
Recruiting
- Conditions
- dystonia.Dystonia
- Registration Number
- IRCT20211019052811N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with focal-generalized dystonia
Failure to improve the patient's dystonic symptoms with previous drug treatments
Exclusion Criteria
Evidence that dystonia is secondary to other diseases
History of liver disease
Pregnancy or intent to conceive or breastfeed
History of dystonic surgery, including deep brain stimulation and destructive surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity of dystonia motion symptoms based on Van Marsden Scale and Global Dystonia Scale and TWSTRS. Timepoint: Before the intervention (0), then 3, 6, and 9 weeks after the start of the intervention or placebo. Method of measurement: Van Marsden Scale and Global Dystonia Scale and TWSTRS.
- Secondary Outcome Measures
Name Time Method Quality of life using SF-36 questionnaire. Timepoint: Before the intervention (0), then 3, 6, and 9 weeks after the start of the intervention or placebo. Method of measurement: SF-36 questionnaire.